GITNUXSOFTWARE REVIEW
Science ResearchTop 10 Best Health Industries Research Services of 2026
Compare health industries research services for buyers, with side-by-side options and tradeoffs for firms evaluating ZS Associates, Deloitte, or Kantar.
How we ranked these tools
Vendors set the topic, but our editors set the inclusion criteria and the evaluation framework before research starts.
AI search agents find sources, extract figures with provenance, and aggregate written reviews. They also transcribe video reviews and podcasts.
Framework: Features 40% · Ease 30% · Value 30%
Gitnux may earn a commission through links on this page — this does not influence rankings. Editorial policy
ZS Associates is the best pick for payer, provider, or biopharma teams needing interview-based primary research turned into pathway-level segmentation and decision-ready analytics, while Deloitte is the better fit for integrated stakeholder market intelligence that supports market-access assumptions in one consulting narrative.
Editor’s top 3 picks
Three quick recommendations before you dive into the full comparison below — each one leads on a different dimension.
ZS Associates
Interview-based research synthesis tied directly to segmentation and pathway-level recommendations, delivered through a tightly governed study plan.
Best for: Fits when payer, provider, or biopharma teams need structured primary research plus analytics for market access decisions.
Deloitte
Editor pickCross-workstream synthesis that ties healthcare stakeholder interviews to market access research assumptions in one decision narrative.
Best for: Fits when integrated healthcare market intelligence needs stakeholder input plus market access and pathway implications.
Kantar
Editor pickGlobal research execution with standardized deliverable packs tailored to provider and payer stakeholder analysis workflows.
Best for: Fits when multinational health insights programs need managed fieldwork and decision-ready deliverables.
Comparison Table
ZS Associates
specialistManagement consulting and research firm specializing in pharmaceutical and medical device industries.
Interview-based research synthesis tied directly to segmentation and pathway-level recommendations, delivered through a tightly governed study plan.
ZS Associates runs health industries research programs that translate stakeholder input into market sizing, segmentation, and go-to-market recommendations. The firm is known for structured consulting workflows that combine primary research, competitive intelligence, and analytics to support provider and payer market decisions.
Its engagements often include blueprinting for care delivery and treatment pathways, alongside evidence synthesis for standards of care and unmet need. ZS Associates is distinct for driving research through tightly managed study plans and decision-grade outputs geared toward execution stakeholders.
- +Disciplined end-to-end research program management for decision-grade outputs
- +Strong qualitative-to-analytics translation from stakeholder interviews
- +Clear focus on provider and payer market questions in study design
- +Methodical competitive intelligence workflows tied to segmentation
- –Project work is delivery-led, not an internal self-serve research workflow
- –Less suited for teams needing an always-on data API or embedded tooling
- –Execution timelines depend on primary research access and fieldwork staffing
- –Customization depth can require close governance on study scope
Market access and reimbursement teams
Plan access and reimbursement strategy
Access planning supported
Clinical and evidence generation teams
Design real-world evidence analyses
Evidence execution ready
Show 2 more scenarios
Sales leadership and commercial ops
Redesign sales and incentive approach
Structured sales processes
Advise on sales strategy, incentive compensation, and field operations to improve commercial organization effectiveness.
Healthcare commercial strategy teams
Run structured expert interview synthesis
Qualitative insights compiled
Plan structured interviews with stakeholders and synthesize qualitative findings into strategic implications.
Best for: Fits when payer, provider, or biopharma teams need structured primary research plus analytics for market access decisions.
Deloitte
enterprise_vendorBig Four consulting firm with a dedicated health industries practice covering research and strategy.
Cross-workstream synthesis that ties healthcare stakeholder interviews to market access research assumptions in one decision narrative.
Deloitte works well for healthcare market intelligence that needs cross-domain integration between payer strategy, provider market analysis, and biopharma market research. Teams commonly produce research outputs that map stakeholder perspectives to market sizing and forecasting assumptions, including segmentation for uptake, access constraints, and adoption drivers. Delivery typically fits organizations that need healthcare stakeholder interviews, plus structured synthesis for treatment pathway analysis and standard-of-care assessment decisions. Comparable providers like Mathematica and RTI often skew toward academic-grade quant and policy modeling depth, while IQVIA may emphasize commercial datasets and field research operations.
A key tradeoff for Deloitte is that engagements skew toward consulting-style cadence and governance, which can slow iterative research cycles versus methods-driven labs that offer faster turnarounds for single hypotheses. Deloitte is a strong fit when a buyer needs multiple workstreams coordinated into one decision narrative, such as simultaneous payer and provider landscape work. Deloitte is less ideal when the primary requirement is rapid, narrow quantitative output with minimal stakeholder work.
For buyer evaluation, Deloitte competes most directly on integration breadth across stakeholders and the ability to convert qualitative research into actionable market access research themes.
- +Consulting-led research synthesis across payers, providers, and life sciences stakeholders
- +Structured stakeholder interview programs feeding market access decision framing
- +Analytics delivery that supports evidence-based claims style investigations
- +Coordinated multi-workstream studies for care pathway and competitive intelligence
- –Turnaround can be slower for single-question, rapid iteration needs
- –Requires active buyer governance to keep assumptions aligned across workstreams
- –Not optimized for self-serve, rapid dashboarding workflows without project management
- –Depth of specific methods can depend on the assigned analytics team and scope
Payer strategy teams
Plan coverage strategy for a therapy class
Coverage approach and targeting
Provider network leaders
Assess adoption impact by care pathway
Implementation priorities
Show 2 more scenarios
Biopharma marketing
Competitive intelligence for pipeline positioning
Launch narrative and claims
Treatment pathway analysis and standard-of-care comparisons translate qualitative signals into positioning implications.
Medical device commercialization
Market sizing and access barriers study
Go-to-market focus areas
Provider market analysis pairs demand segmentation with access and payer policy themes.
Best for: Fits when integrated healthcare market intelligence needs stakeholder input plus market access and pathway implications.
Kantar
specialistGlobal research and insights firm with a health division serving pharma and consumer health clients.
Global research execution with standardized deliverable packs tailored to provider and payer stakeholder analysis workflows.
Kantar serves health industries research with mixed-method work that combines branded survey programs and qualitative healthcare research support across markets. The service delivery is oriented around structured deliverables for provider market analysis and healthcare market intelligence, including segmentation outputs and decision-ready reporting packs.
Kantar also supports data-driven competitor and pipeline analysis using study design, fieldwork management, and analytics workflows that map to payer, provider, and biopharma stakeholder needs. Integration depth depends on engagement setup because the research outputs are typically packaged for downstream use rather than operating as a single unified analytics product.
- +Structured mixed-method studies for healthcare stakeholder interviews and segmentation outputs
- +Health-focused analyst workflows for provider market analysis across countries
- +Strong execution management for multi-wave survey and qualitative studies
- +Clear deliverable formats aimed at payer, provider, and biopharma decision needs
- –Automation and API surfaces are limited compared with pure research analytics products
- –Data ingestion and configuration require engagement-specific onboarding
- –Less suited for real-time claims data analysis automation without project support
Longitudinal research teams
Track respondents across multiple study waves
Comparable wave results
Global innovation and product teams
Prioritize concepts across regions
Concept investment prioritized
Show 2 more scenarios
Public affairs and policy teams
Measure attitudes for stakeholder decisions
Decision-ready evidence
Deliver managed qualitative and quantitative research on opinions and behaviors for structured evidence.
Media and marketing leaders
Evaluate media and audience performance
Audience insights generated
Combine media measurement with audience research to assess campaign evaluation and planning inputs.
Best for: Fits when multinational health insights programs need managed fieldwork and decision-ready deliverables.
KLAS Research
specialistHealthcare IT research firm collecting vendor performance data from provider organizations.
Cross-customer vendor evaluations that translate user feedback into comparable ratings and decision narratives.
KLAS Research collects input from healthcare leaders and operational users to assess real-world performance of health technology and services. Coverage commonly spans applications and service relationships that affect frontline workflows, including implementation experience, support quality, and outcomes tied to day-to-day use. The research delivery format favors decision-ready narratives and comparative views that can be used in internal market reviews.
- +Vendor comparisons grounded in documented, recurring customer feedback
- +Clear performance themes tied to deployment and day-to-day support
- +Outputs written for healthcare procurement and executive briefings
- +Consistent research cycle supports year-over-year benchmarking
- –Custom data builds are not the primary research delivery mechanism
- –Some findings reflect qualitative feedback more than measured clinical endpoints
- –Coverage depth can vary by category and region based on respondent volume
IT procurement teams
Select vendors using third-party comparisons
Faster, defensible vendor decisions
Vendor product managers
Prioritize fixes from structured feedback
Clear roadmap prioritization
Show 2 more scenarios
Health system executives
Support governance and vendor oversight
Stronger vendor governance
Executives use comparative research outputs to align stakeholders on performance expectations and accountability.
Strategic planning leaders
Benchmark technology investments across markets
Better portfolio alignment
Planning teams benchmark vendor performance across categories to guide investment pacing and standardization decisions.
Best for: Fits when healthcare organizations need benchmarked vendor performance insights for procurement and vendor governance.
PwC
enterprise_vendorBig Four firm operating the Health Research Institute for healthcare industry analysis and forecasting.
Integrated consulting delivery that pairs stakeholder engagement with structured competitive and market-access synthesis.
PwC can run healthcare market intelligence studies that combine qualitative input from healthcare stakeholders with quantitative analysis needed for provider market analysis and payer market analysis. Delivery commonly includes structured research plans, interview and advisory engagement workflows, and end-to-end synthesis into decision-ready deliverables for leadership teams. Governance tends to be stronger than small research boutiques because PwC teams usually manage cross-functional workstreams and internal review gates across strategy and analytics.
- +Cross-stakeholder health research backed by consulting delivery governance
- +Structured stakeholder engagement workflows for clinician and payer audiences
- +Analytical synthesis that connects market signals to implementation decisions
- +Consistent workstream management across strategy and analytics teams
- –Less suited to rapid, self-serve research cycles without project leadership
- –Research turnaround can depend on coordination across multiple stakeholders
Market access strategy teams
Build payer-focused competitive access narrative
Clear market access priorities
Provider transformation leaders
Assess care delivery adoption barriers
Actionable adoption roadmap
Show 1 more scenario
Biopharma competitive intelligence
Evaluate therapeutic landscape and positioning
Cohesive competitive positioning
Competitive assessment work connects evidence narratives to differentiated positioning and stakeholder expectations.
Best for: Fits when executives need coordinated research synthesis for market access and competitive strategy planning.
IQVIA
enterprise_vendorGlobal provider of clinical research, healthcare data, and commercial analytics for the life sciences sector.
Market intelligence workflows that integrate claims and EHR evidence with competitive and pipeline analysis for commercial and market access decisions.
IQVIA is a healthcare industries research service provider focused on healthcare market intelligence, combining primary research with large-scale analytical assets. Its deliverables commonly span provider market analysis and payer market analysis, plus biopharma and medical device market research that ties competitive context to forecasting.
- +Consistent delivery across provider, payer, and biopharma market analysis workstreams
- +Strong claims and EHR driven evidence generation for real-world evidence briefs
- +Proven approach to competitive intelligence tied to pipeline and standard-of-care assessment
- +Structured stakeholder research methods for interviews and clinician advisory board inputs
- –Automation and API surfaces are not the primary buying motion for most engagements
- –Governance for data access and lineage can add lead time for regulated datasets
- –Customization depth can require tighter scope management to avoid rework
- –Qualitative synthesis can vary by study team composition and methodology package
Translational and clinical teams
Execute biomarker-led study planning
Biomarker execution coordinated
Medical writing and regulatory teams
Produce controlled submission documents
Submission-ready documents
Show 2 more scenarios
Healthcare marketing and provider strategy
Measure patient and referral outcomes
Governed impact reporting
Connect campaign exposure and provider activity to patient acquisition and service-line demand outcomes.
Medtech market access teams
Plan adoption using cross-market inputs
Adoption insights across markets
Combine payer, provider, clinical, and real-world inputs to support adoption and portfolio decisions.
Best for: Fits when healthcare market research needs large-data evidence plus recurring competitive and access analysis.
Oliver Wyman
enterprise_vendorManagement consulting firm with a health and life sciences practice producing industry research.
Interview-first research programs that connect qualitative findings to market access framing for payers and providers.
Oliver Wyman is a consulting-led health industries research service provider used by sponsors needing clinician and stakeholder input tied to market access implications. Its core capabilities center on healthcare market intelligence, healthcare stakeholder interviews, and provider market analysis for regions, segments, and care settings.
- +Strong execution of healthcare stakeholder interviews with structured evidence synthesis
- +Provider market analysis that maps competitive dynamics across care settings
- +Clear translation from research findings to market access and coverage implications
- +Experienced teams for qualitative healthcare research and decision framing
- –Less suited for buyers needing automated API-based delivery of datasets
- –Reusable data assets and publishing workflows are not the center of the offering
- –Timeline and scope are driven by consulting delivery cycles rather than self-serve operations
Payer strategy teams
Assess clinician input for access strategy
Access implications clarified
Provider network leaders
Analyze competitive care setting dynamics
Care setting strategy guidance
Show 2 more scenarios
Regional stakeholder groups
Build treatment pathway insight from interviews
Pathway recommendations prepared
Synthesize primary research and secondary evidence into treatment pathway analysis for strategy-ready recommendations.
Strategy and transformation leaders
Plan regulated-sector healthcare transformation
Coordinated transformation plan
Combine industry strategy, risk analysis, and program governance to coordinate transformation under constraints.
Best for: Fits when teams need stakeholder-led healthcare market intelligence tied to provider or payer decisions.
L.E.K. Consulting
specialistStrategy consulting firm with a strong life sciences and healthcare research practice.
Senior-led synthesis that translates healthcare stakeholder interviews into decision scenarios for provider and payer strategy.
L.E.K. Consulting is a health industries research partner for buyers needing provider market analysis and payer market analysis tied to strategy decisions. Delivery centers on senior consulting teams producing both qualitative healthcare research and quantitative healthcare research outputs with clear implications for market access and competitive positioning.
- +Strategy-ready provider and payer market analysis backed by consulting synthesis
- +Structured healthcare stakeholder interviews with documented question guides and themes
- +Competitive intelligence and pipeline analysis tied to decision scenarios
- +Senior-led delivery that aligns findings to market access implications
- –Requires active client participation in interview scheduling and feedback loops
- –Automation and API surfaces are not positioned for direct data connectivity
- –Less suited for high-throughput self-serve slicing and dashboard iteration
- –Turnaround depends on qualitative input availability and validation checkpoints
Pricing and commercial finance teams
Validate pricing trade-offs and packaging
Pricing recommendation governed
International expansion teams
Plan market entry with competition context
Entry plan and roadmap
Show 2 more scenarios
Biotech business development teams
Evaluate partnership and licensing opportunities
Deal terms supported
Analyze market potential and strategic fit to support partnership priorities and deal terms evidence.
Healthcare procurement and supply chain leaders
Develop supply market strategy
Sourcing strategy defined
Use market analysis to inform procurement, supplier, and supply chain strategy decisions.
Best for: Fits when a health-focused strategy team needs senior-led market analysis for provider or payer decisions.
Ipsos
specialistGlobal market research firm with a healthcare division providing pharmaceutical and medical device research.
Large-scale stakeholder research delivery that coordinates mixed methods work across healthcare roles and geographies.
Ipsos executes health technology market research and healthcare market intelligence using study design, recruitment, interviewing, and analytics into structured deliverables.
- +Multi-stakeholder study design supports provider, payer, and biopharma questions
- +Strong interviewing execution for qualitative healthcare research synthesis
- +Competitive intelligence outputs map well to pipeline and market access decisions
- +Clear project deliverables reduce internal coordination for research programs
- –Limited evidence of a buyer-facing API for automated data provisioning
- –Automation and extensibility are project-led rather than platform-led
- –Requires active governance to keep cross-country fieldwork consistent
- –Integration depth is weaker than vendors offering direct data platform connections
Strategy and commercial teams
Assess market opportunity with primary research
Market assessment supported
Multinational insights teams
Run surveys across countries consistently
Cross-market comparable findings
Show 2 more scenarios
Public affairs and polling teams
Field surveys for public opinion evidence
Public opinion evidence
Design and field surveys to measure attitudes for structured evidence and decision-making.
Brand and marketing teams
Test brand health and concepts
Positioning evidence generated
Assess brand, product concepts, or messaging through survey and qualitative research inputs.
Best for: Fits when organizations need executed health research deliverables with minimal internal research ops overhead.
ECG Management Consultants
specialistHealthcare consulting firm providing strategic advisory and research for hospitals and health systems.
End-to-end consulting research workstreams that translate stakeholder interviews into provider and payer decision materials.
ECG Management Consultants delivers health industries research focused on provider market analysis and health technology market research for stakeholders that need evidence tied to commercial and care delivery decisions. The firm is structured around consulting-style workstreams that translate qualitative healthcare research inputs into actionable findings for organizations evaluating where to invest or partner.
- +Consulting-led research synthesis for provider and payer market decisions
- +Structured qualitative healthcare research workflow with interview-based evidence
- +Benchmarking outputs geared to competitive intelligence comparisons
- +Clear deliverable framing for executive and strategy review cycles
- –Automation and API surface for programmatic research workflows is not evident
- –Low transparency into integration depth with client data systems
- –Turnaround depends on analyst availability and study scope
- –Limited self-serve tooling for iterative exploration without a new engagement
Hospital technology leaders
Plan technology initiatives with clinical constraints
Aligned technology plan
Health system nursing leaders
Plan clinical workforce changes
Staffing recommendations
Show 2 more scenarios
Medical group operations leaders
Redesign practice workflows and capacity
Operational redesign steps
Review scheduling, staffing, documentation, and provider capacity to guide operational redesign steps.
Revenue cycle finance leaders
Improve denial and collection workflows
Remediation priorities documented
Assess access, coding, claims denials, appeals, and follow-up workflows to identify remediation priorities.
Best for: Fits when organizations need consulting-grade healthcare market intelligence deliverables and structured interview synthesis.
Conclusion
After evaluating 10 health industries research, ZS Associates stands out as our overall top pick — it scored highest across our combined criteria of features, ease of use, and value, which is why it sits at #1 in the rankings above.
Use the comparison table and detailed reviews above to validate the fit against your own requirements before committing to a tool.
Frequently Asked Questions About Health Industries Research
Which service fits buyer benchmarking for health technology vendor performance across customers?
How does Deloitte convert payer and provider stakeholder interviews into market access research assumptions?
When do Mathematica-style quant policy models outperform consulting-led interview synthesis?
What breaks if a team needs a bespoke dataset built directly from raw operational sources?
How does IQVIA handle evidence depth for claims, EHR, and real-world evidence in market intelligence workflows?
What tradeoff appears when the research must cover both care pathways and patient journey mapping with one coordinated program?
When is a global fieldwork execution model more valuable than a reusable analytics platform?
How do admin controls and audit trail expectations affect onboarding for stakeholder research projects?
Which provider best fits a workflow that converts stakeholder interviews into packaged decision materials for cross-functional reviews?
Tools reviewed
Primary sources checked during evaluation.
Referenced in the comparison table and product reviews above.
How to Choose the Right Health Industries Research
We separate health industries research options by how they handle primary sources and market segmentation, and whether they keep work consistent from sourcing to outputs. The biggest practical differences show up in Data coverage and definitions, Output export workflow, and API and automation surface.
Source coverage and segment definitions
Why it matters
Health industries research results can shift a lot depending on which source types are included and how segments are defined (providers, payers, life sciences, devices, digital health). Clear definitions also reduce “apples-to-oranges” comparisons across releases.
How to check
Ask for a sample report and check the methodology section for source categories and segment cut rules. Then compare two segments in the sample for consistent inclusion/exclusion language.
Evidence traceability to cited inputs
Why it matters
Health industries research needs evidence traceability so stakeholders can validate claims behind forecasts, sizing, or competitive summaries. When traceability is weak, teams spend time re-researching.
How to check
In a demo, click through a key statistic and verify you can reach the underlying cited input or note. Ask whether citations travel into exported documents (PDF/Slides/Docs).
Export workflow for reports and slides
Why it matters
In health industries research, the final asset is often a board-ready deck or memo. A strong export workflow preserves charts, tables, and wording so teams don’t rebuild outputs manually.
How to check
Request an export of a sample workspace: one report view and one chart/table view. Confirm the exported file keeps filters, time windows, and unit conventions you selected.
API and automation surface for updates
Why it matters
We see recurring value when health industries research updates can be scheduled or programmatically pulled into internal workflows. API and automation reduce copy-paste and keep teams on the same version of the analysis.
How to check
Ask what actions can be automated: refreshing datasets, triggering report generation, and pulling results by parameters. If an API exists, review example calls or a sandbox response that returns analysis artifacts.
Filtering controls for geographies and segments
Why it matters
Health industries research often depends on tight scoping: country/region, provider type, payer type, or life sciences subcategory. Better filtering controls help teams avoid vague averages.
How to check
In the interface, apply two different scopes and verify the outputs change in the same places (tables, narratives, and chart legends). Ask how the tool handles “unknown” or missing segment mappings.
Red flags
- Exports don’t keep the same filters, units, or time windows you selected
- Key numbers can’t be traced to cited inputs or notes during review
- Segment definitions are vague or change without clear versioning
Fit by situation
- If we need consistent board-ready outputs from health industries research, prioritize Output workflow for reports and slides.
- If we integrate frequent updates into internal dashboards, prioritize API and automation surface for updates.
- If stakeholders must validate assumptions quickly, prioritize Evidence traceability to cited inputs.
Funding and competing interests
This study was co-funded by several of the vendors assessed in it. No single vendor funded it. Funders could propose the market studied.
They had no role in selecting vendors, setting or weighting criteria, analysing data or drawing conclusions, and they received the same factual-accuracy check as every other vendor assessed.
Market definition, inclusion rules and criteria weights were fixed by an editor before research began and did not change afterwards. Editorial process →
- Service review · 2026 · Science ResearchHealth Care Research
- Service review · 2026 · Regulated Controlled IndustriesHealth Care Compliance
- Service review · 2026 · Market ResearchHealthcare Competitive Intelligence
- Review · 2026 · Science ResearchHealthcare Simulation Software
- Review · 2026 · AI In IndustryIndustries Software
Keep exploring
Comparing two specific tools?
Software Alternatives
See head-to-head software comparisons with feature breakdowns, pricing, and our recommendation for each use case.
Explore software alternatives→In this category
Science Research alternatives
See side-by-side comparisons of science research tools and pick the right one for your stack.
Compare science research tools→